Search

Author/Creator Chavakis, T.

5. P449: NOVEL, FIRST-IN-CLASS, SOMATIC IDH2 DELETION-INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN-VITRO. (23rd June 2022)

Authors:
Ruhnke, L.; Poitz, D. M.; Herold, S.; Dressler, S.; Dill, C.; Peitzsch, M.; Oelschlägel, U.; Frimmel, J.; Kunadt, D.; Kretschmann, T.; Altmann, H.; Stölzel, F.; Röllig, C.; Chavakis, T.; Baretton, G.; Schäfer-Eckart, K.; Bornhäuser, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
349
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P752: TARGETING S100A9 IN THE MYELODYSPLASTIC INFLAMMATORY BONE MARROW MICROENVIRONMENT BY TASQUINIMOD IMPROVES THE SUPPORTIVE FUNCTION OF MESENCHYMAL STROMAL CELLS. (23rd June 2022)

Authors:
Wobus, M.; Balaian, E.; Lissner, M.; Towers, R.; Oelschlägel, U.; Wehner, R.; Chavakis, T.; Törngren, M.; Eriksson, H.; Bondesson, E.; Platzbecker, U.; Bornhäuser, M.; Sockel, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗